Arvinas price target lowered to $65 from $77 at Leerink

Leerink lowered the firm’s price target on Arvinas to $65 from $77 due to dilution following the $350M private placement in Q4 2023 and subsequently the full recognition of the equity impact to shares in Q1 2024. The firm keeps an Outperform rating on the shares following quarterly results.